Senti Biosciences Holdings, Inc.
SNTINasdaqCIK 1854270HealthcareFiscal year ends Dec 31
Reports and events: 127 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:17 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-040772 |
| 2026-10-1516:02 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-065992 |
| 2026-10-1316:01 ET | 8-K | 8.01 Other events | 0001628280-26-065685 |
| 2026-09-2416:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-063369 |
| 2026-09-1117:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-003795 |
| 2026-09-0406:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-060600 |
| 2026-09-0216:29 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice | 0001628280-26-060124 |
| 2026-08-2016:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-058258 |
| 2026-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-057110 |
| 2026-07-1613:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-003126 |
| 2026-07-1507:32 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-048248 |
| 2026-05-2616:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-038058 |
| 2026-05-1416:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-035126 |
| 2026-05-1408:48 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-034834 |
| 2026-05-0417:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-002262 |
| 2026-05-0116:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.01 Change in control; 9.01 Financial statements and exhibits | 0001628280-26-029320 |
| 2026-04-2916:41 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001628280-26-028429 |
| 2026-04-1616:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-044433 |
| 2026-04-0116:31 ET | 8-K | 8.01 Other events | 0001628280-26-022824 |
| 2026-03-3117:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000301 |
| 2026-03-2708:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-021580 |
| 2026-03-2708:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021578 |
| 2026-03-1916:02 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-26-019789 |
| 2026-01-2016:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-000314 |
| 2025-12-0907:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055953 |
| 2025-11-1317:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-052125 |
| 2025-11-1316:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052083 |
| 2025-09-0208:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-003924 |
| 2025-08-0708:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001854270-25-000090 |
| 2025-08-0708:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000088 |
| 2025-07-1808:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001854270-25-000077 |
| 2025-06-3016:02 ET | 8-K | 5.07 Shareholder vote results | 0001854270-25-000073 |
| 2025-06-1807:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001854270-25-000069 |
| 2025-05-0616:48 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001854270-25-000065 |
| 2025-05-0616:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000062 |
| 2025-04-3016:24 ET | DEF 14A | Proxy statementPeriod 2025-06-25 | 0001854270-25-000054 |
| 2025-04-2807:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001854270-25-000046 |
| 2025-03-2406:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-009939 |
| 2025-03-2017:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001854270-25-000042 |
| 2025-03-2016:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000038 |
| 2025-03-1718:35 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-024530 |
| 2025-03-1715:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001079973-25-000398 |
| 2025-03-1316:31 ET | SCHEDULE 13D | Ownership report, active investor | 0001079973-25-000383 |
| 2025-03-1019:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-25-000223 |
| 2025-03-1016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-007862 |
| 2025-03-0717:18 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-007658 |
| 2025-02-2516:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001854270-25-000008 |
| 2025-02-0617:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-004293 |
| 2025-01-2707:30 ET | DEF 14A | Proxy statementPeriod 2025-03-06 | 0001140361-25-001942 |
| 2025-01-0616:01 ET | 8-K | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000337 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.